Khosla C, McDaniel R, Ebert-Khosla S, Torres R, Sherman D H, Bibb M J, Hopwood D A
Department of Genetics, John Innes Institute, John Innes Centre, Norwich, United Kingdom.
J Bacteriol. 1993 Apr;175(8):2197-204. doi: 10.1128/jb.175.8.2197-2204.1993.
The gene that encodes the acyl carrier protein (ACP) of the actinorhodin polyketide synthase (PKS) of Streptomyces coelicolor A3(2) was replaced with homologs from the granaticin, oxytetracycline, tetracenomycin, and putative frenolicin polyketide synthase gene clusters. All of the replacements led to expression of functional synthases, and the recombinants synthesized aromatic polyketides similar in chromatographic properties to actinorhodin or to shunt products produced by mutants defective in the actinorhodin pathway. Some regions within the ACP were also shown to be interchangeable and allow production of a functional hybrid ACP. Structural analysis of the most abundant polyketide product of one of the recombinants by electrospray mass spectrometry suggested that it is identical to mutactin, a previously characterized shunt product of an actVII mutant (deficient in cyclase and dehydrase activities). Quantitative differences in the product profiles of strains that express the various hybrid synthases were observed. These can be explained, at least in part, by differences in ribosome-binding sites upstream of each ACP gene, implying either that the ACP concentration in some strains is rate limiting to overall PKS activity or that the level of ACP expression also influences the expression of another enzyme(s) encoded by a downstream gene(s) in the same operon as the actinorhodin ACP gene. These results reaffirm the idea that construction of hybrid polyketide synthases will be a useful approach for dissecting the molecular basis of the specificity of PKS-catalyzed reactions. However, they also point to the need for reducing the chemical complexity of the approach by minimizing the diversity of polyketide products synthesized in strains that produce recombinant polyketide synthases.
将天蓝色链霉菌A3(2)放线紫红素聚酮合酶(PKS)的酰基载体蛋白(ACP)编码基因,替换为来自granaticin、土霉素、四环素霉素以及假定的弗罗利辛聚酮合酶基因簇的同源基因。所有这些替换都导致了功能性合酶的表达,并且重组体合成的芳香族聚酮化合物在色谱性质上与放线紫红素相似,或者与放线紫红素途径有缺陷的突变体产生的分流产物相似。ACP内的一些区域也显示是可互换的,并能产生有功能的杂合ACP。通过电喷雾质谱对其中一个重组体最丰富的聚酮产物进行结构分析表明,它与变构菌素相同,变构菌素是之前已鉴定的actVII突变体(缺乏环化酶和脱水酶活性)的分流产物。观察到表达各种杂合合酶的菌株在产物谱上存在定量差异。这些差异至少部分可以通过每个ACP基因上游核糖体结合位点的差异来解释,这意味着在某些菌株中ACP浓度对整体PKS活性是限速的,或者ACP表达水平也影响与放线紫红素ACP基因在同一操纵子中由下游基因编码的另一种酶的表达。这些结果再次证实了这样的观点,即构建杂合聚酮合酶将是剖析PKS催化反应特异性分子基础的一种有用方法。然而,它们也指出需要通过最小化产生重组聚酮合酶的菌株中合成的聚酮产物的多样性来降低该方法的化学复杂性。